Journey Legacy Partners, LLC (JLP), a private investment and operating firm led by medical device and life sciences executive Jeff Journey, announces the formation of Journey Actuating Technologies, Inc. (dba RxActuator) and the acquisition of 100% of the assets and intellectual property of RxActuator, Inc. and Medipacs. Backed by founder capital and execution-focused leadership, the acquisition marks the commercial relaunch of the RxActuator Mini-Infuser®, a validated, commercial-stage platform positioned at the forefront of the rapidly expanding “hospital-at-home” movement in veterinary medicine.
Read the full article: RxActuator Acquisition Disrupts Veterinary Care with Multispecies ‘Hospital-at-Home’ Infusion Platform //
Source: https://www.einpresswire.com/article/900263750/rxactuator-acquisition-disrupts-veterinary-care-with-multispecies-hospital-at-home-infusion-platform